newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Reports First Quarter 2021 Operating and Financial Results

CAMBRIDGE, Mass., May 07, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial and operating results for the three